• DOI:10.5582/DDT.2011.V5.6.266
Corpus ID: 11520385

Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1.

@article{Maruta2011EffectiveNT,
  title={Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1.},
  author={H. Maruta},
  journal={Drug discoveries & therapeutics},
  year={2011},
  volume={5 6},
  pages={
          266-78
        }
}

• H. Maruta
• Published 2011
• Biology, Medicine
• Drug discoveries & therapeutics

Neurofibromatosis (NF) is a family of genetic diseases which are caused by dysfunction of either NF1 gene or NF2 gene. One in 3,000 people suffer from this tumor-carrying NF. NF1 gene product is a RAS GTPase activating protein (GAP) of 2,818 amino acids, which normally attenuates the GTP-dependent signal transducing activity of the G protein RAS. Dysfunction of this GAP leads to the abnormal activation of RAS, and eventually an oncogenic kinase called PAK1 as well. NF2 gene product is ''Merlin… Expand

View on PubMed

jstage.jst.go.jp

Save to Library

Create Alert

Cite

Launch Research Feed